Once-weekly dulaglutide versus once-daily liraglutide in metformin-treated patients with type 2 diabetes (AWARD-6): a randomised, open-label, phase 3, non-inferiority trial (Q42671884)
Jump to navigation
Jump to search
scientific article published on 10 July 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Once-weekly dulaglutide versus once-daily liraglutide in metformin-treated patients with type 2 diabetes (AWARD-6): a randomised, open-label, phase 3, non-inferiority trial |
scientific article published on 10 July 2014 |
Statements
1 reference
Once-weekly dulaglutide versus once-daily liraglutide in metformin-treated patients with type 2 diabetes (AWARD-6): a randomised, open-label, phase 3, non-inferiority trial (English)
1 reference
Kathleen M Dungan
1 reference
Santiago Tofé Povedano
1 reference
Thomas Forst
1 reference
José G González González
1 reference
Charles Atisso
1 reference
Whitney Sealls
1 reference
Jessie L Fahrbach
1 reference
10 July 2014
1 reference
Identifiers
1 reference